ArticleInternational journal of dermatology2022

Plasmapheresis: a feasible choice for bullous pemphigoid patients infected with SARS-CoV-2.

Yu Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.